Carvedilol Tablet, Film Coated
Product Images NDC 51407-040

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 51407-040). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Chemical structure diagram of Carvedilol, showing its molecular composition and arrangement of atoms as represented by rings and chains typical for this active ingredient.*

FDA Label Image

Figure-1 (Figure 1)

A line graph comparing mortality percentages over time in months between placebo and carvedilol groups. The vertical axis represents % mortality from 0 to 30%, and the horizontal axis shows months from 0 to 21. The carvedilol group shows consistently lower mortality than placebo, with a p-value of 0.0014 indicating statistical significance.*

FDA Label Image

Figure-2 (Figure 2)

A forest plot showing hazard ratios across various patient subgroups including gender, age, race, diabetic status, ischemic status, heart rate, systolic blood pressure, spironolactone use, and all patients. Each subgroup is represented by a horizontal line with a central black dot indicating the hazard ratio and whiskers showing confidence intervals, comparing risk metrics related to the treatment or condition under study.*

FDA Label Image

Figure-3 (Figure 3)

A line graph comparing percent mortality over 24 months for Carvedilol versus placebo. The x-axis represents months, and the y-axis represents percent mortality. The graph shows lower mortality with Carvedilol compared to placebo, with a p-value of 0.03 indicating statistical significance.*

FDA Label Image

Figure-4 (Figure 4)

A forest plot chart showing hazard ratios with confidence intervals for various patient subgroups. The chart evaluates outcomes related to conditions such as age, sex, heart failure history, medication use, cardiovascular risk factors, and clinical classifications, comparing different treatments or conditions in a clinical study setting involving Carvedilol.*

FDA Label Image

51407-039-01lb (Carvedilol Tabelts)

Carvedilol 3.125 mg tablets, USP label with NDC 51407-039-01. The label indicates 100 tablets in the package, marketed by GSMS, Incorporated. It advises dispensing patient information with directions to see prescribing information and storage at 25°C (77°F) with permitted excursions. The label includes a barcode and a QR code area for lot, expiration, and serial number details.*

FDA Label Image

51407-040-01lb (Carvedilol Tabelts)

Label for Carvedilol tablets, USP 6.25 mg by Golden State Medical Supply, Inc. The label includes the NDC 51407-040-01, a blue box indicating 6.25 mg strength, and states the package contains 100 tablets. Storage instructions and dispensing requirements are also noted along with a barcode and QR code.*

FDA Label Image

51407-041-01lb (Carvedilol Tabelts)

Label for Carvedilol 12.5 mg film-coated tablets, USP, oral use, containing 100 tablets per container. The label includes the NDC number 51407-041-01, pharmacist dispensing instructions, storage conditions, and a barcode. Marketed by GSMS, Incorporated, Camarillo, CA, with a revision date of 10/23.*

FDA Label Image

51407-042-01lb (Carvedilol Tabelts)

Label for Carvedilol Tablets, USP 25 mg film-coated tablets, marketed by GSMS, Incorporated. The label displays the NDC 51407-042-01 and indicates a package size of 100 tablets. It advises dispensing patient information to each patient and includes storage instructions and child safety warnings.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.